Volunteers Andrew and Dave Cassy shared their experience of supporting Parkinson's research at the latest meeting of the All-Party Parliamentary Group on Parkinson's.
A drug originally developed for prostate cancer may have exciting potential for treating Parkinson's, according to research published today in Cell Stem Cell.
A new neurological patient experience survey has opened, to collect vital information about treatment and care received by people affected by neurological conditions in England.
Scientists have identified a key molecule - called USP13 - which may provide a new avenue to prevent the build up of alpha-synuclein in brain cells.
Results published today in the scientific journal Science Translational Medicine highlights a link between the removal of the appendix and a reduced risk of developing Parkinson's.